Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities ; volume:17 ; number:4 ; day:23 ; month:10 ; year:2024 ; pages:251-253 ; date:12.2024
Magazine of European Medical Oncology ; 17, Heft 4 (23.10.2024), 251-253, 12.2024
- Creator
-
Suppan, Christoph
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-024-00997-3
- URN
-
urn:nbn:de:101:1-2502142137224.907330400590
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suppan, Christoph
- SpringerLink (Online service)
Other Objects (12)
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
Real de-escalation or escalation in disguise?
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
On the Escalation and De-Escalation of Conflict
Gastrointestinal toxicities of proteasome inhibitor therapy
CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients
Differential toxicities of insecticides and halogenated aromatics
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
Real de-escalation or escalation in disguise?
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
On the Escalation and De-Escalation of Conflict
Gastrointestinal toxicities of proteasome inhibitor therapy
CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients
Differential toxicities of insecticides and halogenated aromatics
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
Real de-escalation or escalation in disguise?
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
On the Escalation and De-Escalation of Conflict
Gastrointestinal toxicities of proteasome inhibitor therapy
CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients